07 Jan 2001

Insidon® (Insidon® Dragees) - Deutschland

Updated: 07 Jan 2001

Insidon®

Angst, Spannung, Unruhe, Schlaflosigkeit, depressive Verstimmung, Konzentrationsschwäche, nervöse Erschöpfung. Vegetativ-funktionelle Organbeschwerden. Klimakterische Beschwerden. Psychoreaktive Störungen.

Insidon® Description, Presentation and Dosage

Insidon® Description

Insidon® Drug Class Description

Einzelstoffe

Insidon® Drug Description

1 Drg. enth.: Opipramol-2HCl 50 mg.

Insidon® Generic Name

Insidon® Dragees

Insidon® Presentation

Insidon® Presentation

Insidon®

Insidon® Manufacturer

Novartis Pharma

Related Learning Zones

Hypogonadism Knowledge Centre

Hypogonadism Knowledge Centre

The Hypogonadism Knowledge Centre provides healthcare professionals with free access to disease awareness sections such as epidemiology, pathophysiology, signs and symptoms, treatment options to assist the process of diagnosis, treatment and monitoring of patients with the condition. The regularly updated publications digest area contains analysis and comment on recent scientific articles related to male hypogonadism.

G.MKT.GM.MH.01.2016.0364

Hyperammonaemia Knowledge Centre

Hyperammonaemia Knowledge Centre

The Hyperammonaemia Knowledge Centre has been developed to raise awareness of this rare yet potentially deadly condition. Using this resource, healthcare professionals are encouraged to recognise the signs and symptoms of hyperammonaemia and begin the correct treatment immediately.

Insidon® Dosage

Insidon® Adult Dosage

Copolyvidon, Eisen(III)-oxid (E 172), Glycerol, Hypromellose, Lactose, Macrogol, Magnesiumstearat, Maisstärke, Povidon, Saccharose, Talkum, Titandioxid (E 171).

Insidon® Precautions, Reactions and Contraindications

Insidon® Special Precautions

Insidon® Special Precautions

T 60 a-d

Insidon® Adverse Reactions

Insidon® Adverse Reactions

T 60

Related Drugs - Psychiatry/Mental Health

Back to top